BioAge Labs (BIOA) Shareholder's Equity (2023 - 2026)

BioAge Labs (BIOA) Shareholder's Equity (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 8.23 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 3.23 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 5.90 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 407.18 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 3.41 Bn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 6.50 Bn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 1.75 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 446.17 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 1.21 Bn
10 BioAge Labs 671.19 Mn 288.00 Mn -10.37 Mn 379.12 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 379.12 Mn
Dec 31, 2025 272.05 Mn
Sep 30, 2025 277.46 Mn
Jun 30, 2025 294.78 Mn
Mar 31, 2025 313.17 Mn
Dec 31, 2024 323.13 Mn
Sep 30, 2024 313.75 Mn
Jun 30, 2024 -197.13 Mn
Mar 31, 2024 -185.51 Mn
Dec 31, 2023 -173.40 Mn
Sep 30, 2023 -153.14 Mn